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ABSTRACT We have shown that El and E2 proteins of
human papillomavirus type 11 (HPV-11) were essential to
support the replication of the homologous viral origin (on) in
a transient replication assay, similar to reports on bovine
papillomavirus type 1 (BPV-1). Unexpectedly, matched or even
mixed combinations of El and E2 proteins from HPV-11 or
BPV-l replicated either on in human, monkey, and rodent cell
lines of epithelial or fibroblastic lineage, albeit with varied
efficiencies. Either set of viral proteins was also able to initiate
replication of ori-containing plasmids from many other human
and animal papillomaviruses. Thus the interactions among the
cis elements and trans factors of papillomaviruses are more
conserved than expected from the other members of the
papovavirus family, simian virus 40 and polyomavirus, for
which large tumor antigen does not replicate a heterologous on
in either permissive or nonpermissive cells. We infer that the
stringent species and tissue specificities observed for papillo-
maviruses in vivo are not entirely due to direct restrictions on
viral DNA replication. Rather, transcriptional control of viral
gene expression must play a dominant role.
The initiation ofDNA replication occurs at precisely defined
origins (ori) to which specific control proteins bind. Simian
virus 40 (SV40) and polyomavirus have long been used as
models for investigations of mammalian DNA replication.
Initiation of SV40 or polyomavirus replication requires the
homologous large tumor antigen, is species specific, and
occurs only in a permissive cell environment (1-4). However,
the uncontrolled replication of these lytic viruses does not
reflect the precise regulation of cellular DNA replication,
which takes place once per cell cycle in the S phase. In
contrast, papillomaviruses have regulated and uncontrolled
replication phases during their life cycle and therefore offer
a unique opportunity to study eukaryotic DNA replication.
Human papillomavirus (HPV) types trophic for mucosal
epithelia, including HPV-11, are highly infectious pathogens
that cause genital warts and laryngeal papillomatosis. A
subset of the genital types, including HPV-16 and -18, is also
associated with the development of neoplasia and progres-
sion to cancer. In subclinical or benign infections, viral DNA
persists as low-copy-number plasmids in the nuclei of the
undifferentiated basal stem cells. Productive replication
takes place only in the more differentiated upper strata of the
epithelium. Although a culture system has recently been
developed in which preinfected tissues produce progeny
HPV-11 virions (25), propagation of HPVs has not been
achieved in vitro starting from virions or transfected DNA. In
transfected or infected cells, HPV DNA either integrates into
host chromosomes or is lost. Therefore it has not been
possible, until now, to perform molecular studies of auton-
omous HPV DNA replication in cell culture.
In contrast, bovine papillomavirus type 1 (BPV-1) in trans-
formed rodent cell lines replicates extrachromosomally at a
constant copy number (5) in synchrony with chromosomal
DNA replication (6, 7). Replication of BPV-1 DNA in cul-
tured cells or in cell-free systems depends on two virus-
encoded proteins, the full-length products of the El and E2
open reading frames (ORFs) (8, 9). The minimal BPV-1 ori
sequence is located at the 3' end of the upstream regulatory
region (URR) within a 60-base-pair (bp) DNA fragment
including an (A + T)-rich region, a consensus sequence to
which all papillomaviral E2 proteins bind, and an El protein
binding site spanning nucleotide (nt) 1 (9, 10). The El binding
site is partially conserved among several papillomaviruses
compared (9, 10). The roles of the viral proteins in DNA
replication are still under investigation. The BPV-1 El and E2
proteins form a complex when overproduced in a baculovirus
expression system (11-13). In vitro the E2 protein enhances
El binding to the ori (9).
As a first step in dissecting the requirements forHPV DNA
replication, we expressed the HPV-11 El and E2 proteins
from the adenovirus major late promoter and tested their
abilities to support extrachromosomal replication of a
HPV-11 URR-containing plasmid in different cell lines. The
BPV-1 El and E2 expression plasmids were also used to test
their abilities to support HPV DNA replication. Unexpect-
edly, mixed as well as matched combinations of these two
sets of viral replication proteins were capable of replicating
either viral ori-containing plasmid, with varied efficiencies in
most of the cell lines tested. We also demonstrated the
generality of ori recognition of many heterologous papillo-
maviruses by either set of viral replication proteins.
MATERIALS AND METHODS
Plasmid Construction. The HPV-11 URR-containing plas-
mid, p7072-99, was constructed by transferring the URR
fragment (nt 7072-7933/1-99) flanked by HindIII and Xba I
sites from pUR23-3 (14) into the BamHI site of pML2d (15)
by blunt-end ligation. pMT2-El and pMT2-E2 expressing
HPV-11 El and E2 proteins from the adenovirus major late
promoter were constructed as follows. The El coding frag-
ment between BamHI (nt 812) and Nsi I (nt 2817) was isolated
from pRS/llElA+ (16) and cloned into the cytomegalovirus
immediate early promoter expression vector pcDNA1 (In-
Abbreviations: SV40, simian virus 40; HPV, human papillomavirus;
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vitrogen, San Diego) to generate pCMV-El. It was then
transferred, after addition of EcoRI linkers, into the EcoRI
site ofpMT2 vector (17) to generate pMT2-El. The E2 cDNA
fragment spanning nt 812-847A2622-3900 was isolated from
pRS/llEll2A+ (16) after BamHI and partial Pst I digestion.
It was similarly cloned to generate first pCMV-E2 and then
pMT2-E2. Plasmid pUC/PstI (nt 4780-7945/1-471 in the
pUC19 vector) containing the BPV-1 ori and pCGEag and
pCGE2 expressing the BPV-1 El and E2 protein have been
described previously (8, 10).
The TrpE-ElN fusion protein expression plasmid pATH2-
CM3 contains a HPV-l1 sequence spanning nt 812-1392 plus
3866-4402 cloned into the BamHI and HindIII sites of
pATH2 (18) and encodes the amino-terminal portion (nt
812-1392) of the El ORF (nt 832-2779) and four additional
amino acids before termination. pATHl-E2 containing the
HPV-11 DNA fragment (nt 2756-4556) that spans the bulk of
the E2 ORF (nt 2723-3824) was similarly cloned and ex-
pressed as a TrpE fusion protein.
Preparation ofHPV-ll El and E2 Antibodies. Expression of
TrpE-ElN and E2 fusion proteins was induced with indole-
acrylic acid in bacteria DH5a and HB101, respectively. The
fusion proteins were isolated from polyacrylamide gels and
used as immunogens in 4-month-old female Dutchland rab-
bits. The MPL+TDM emulsion (Ribi Immunochem) was
used as an adjuvant in generating El antibodies, whereas
Freund's adjuvant was used to elicit E2 antibodies. The
specificities of the antisera were confirmed by Western blots
of bacterially expressed proteins.
Western Blotting. Five micrograms of pMT2-E1 and
pMT2-E2 was electroporated with a Gene Pulser (Bio-Rad) at
180 V and 960 ,uF separately into COS-7 cells with 50 ,g of
sheared single-stranded salmon sperm DNA. Cells were
harvested from a 35-mm plate in 200 Al of lx Laemmli buffer
48 hr after electroporation. One-tenth-volume samples were
loaded onto an SDS/10% polyacrylamide gel. Western blot-
ting was performed as described (19) using 1000-fold dilutions
of anti-TrpE-ElN or anti-TrpE-E2 polyclonal antibodies.
Color detection was conducted utilizing the alkaline phos-
phatase system (19).
Transient Replication Assays in Transfected Cells. Chinese
hamster ovary (CHO) cells were maintained in F-12 medium
supplemented with 10%6 fetal bovine serum. NIH 3T3 and 293
cells were grown in Dulbecco's modified Eagle's medium
(DMEM) with 10%6 calf serum. COS-7, C-33A, HeLa, and
SiHa cells were all maintained in DMEM with 10% fetal
bovine serum. Cells were -80% confluent when harvested
for electroporation. Each electroporation mixture contained
0.5 ,ug of supercoiled ori-containing plasmid, 5 ,ug of each
a
812 832
pMT2-El-
protein expression plasmid, and 50 ,ug of carrier DNA.
Electroporation was performed with 5 million cells in 250 Al
of growth medium containing 10%6 fetal bovine serum and 5
mM Bes buffer (N,N-bis[2-hydroxyethyl]-2-aminoethane-
sulfonic acid, pH 7.2) at 960 ,uF and 230 V for CHO cells, 170
V for 293 cells, 200 V for NIH 3T3 and HeLa cells, and 180
V for COS-7, C-33A, and SiHa cells. Transient replication
assays were conducted afterDpn I digestion of inputDNA as
described (8), except that Pst I and EcoRI were used to
linearize HPV-11 and BPV-1 ori plasmids, respectively, in
lysates of low-molecular-weight DNA. One-third of each
lysate was used in Southern blot analysis. Hybridization
probes, as specified in the figure legends, were labeled with
[32P]dCTP by random hexamer priming. Samples at time
points 1, 2, and 3 were collected approximately 36, 60, and 84
hr after electroporation. The length of exposure was given in
each figure legend. The autoradiograms from selected lanes
were traced with an LKB Ultroscan XL densitometer to
estimate the largest fold differences in representative exper-
iments.
RESULTS
Expression of HPV-11 El and E2 Proteins. Autonomous
replication of BPV-1 DNA requires the viral El and E2
proteins (8, 9). We wished to determine whether analogous
viral proteins are required for transient replication of HPV
DNA. Accordingly, HPV-11 El and E2 proteins were ex-
pressed from the human adenovirus major late promoter in
pMT2 expression vectors (Fig. la). When the expression
plasmids were individually electroporated into COS-7 cells
(SV40-transformed monkey kidney CV-1 cells), an 82-kDa
El protein and a 43-kDa E2 protein were detected by Western
blotting when compared to control cells, using polyclonal
antibodies raised against bacterially expressed TrpE fusion
proteins (Fig. lb). Migration of the El protein was somewhat
slower than the anticipated size of 73.5 kDa, whereas the E2
protein was similar to the expected size.
Replication of HPV-11 and BPV-1 on Plasmids by Various
Combinations of Viral El and E2 Proteins. Plasmid p7072-99
contains HPV-11 URR sequences from nt 7072-7933/1-99
and, by analogy to BPV-1, should include the putative ori.
Replication was detected only when HPV-11 El and E2
expression plasmids were cotransfected (Fig. 2a, groups
I-IV) in human 293 cells (adenovirus 5-transformed human
kidney epithelial cells) and CHO cells, in which BPV-1 ori
plasmids also replicate in the presence of homologous viral
replication proteins (10). The HPV-11 El and E2 expression
plasmids did not replicate (data not shown), suggesting
b El E2
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FIG. 1. Expression of HPV-11 El and E2 proteins. (a) El and E2 expression plasmids. pMT2-El and pMT2-E2 express HPV-11 El and E2
proteins from the pMT2 vector (see text). The key components of pMT2 include the SV40 ori and enhancer, the human adenovirus major late
promoter (Ad MLP), tripartite mRNA leader sequence (TPL) and adenovirus-associated small RNA I (VAI) gene, the dihydrofolate reductase
(DHFR) gene, and the SV40 late poly(A) signal and addition site (17). IVS, intervening sequence. (b) Detection of El and E2 proteins in
electroporated COS-7 cells by Western blotting using polyclonal antibodies raised against TrpE-ElN and TrpE-E2 fusion proteins. Arrows point
to protein bands not present in the control cells.
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H H - B H B Although the quantitation of the BPV-1 or HPV-11 repli-B cation proteins was not evaluated in these and subsequent
H - H H B B replication assays, the fact that matched combinations in
l m- m m m m|| |X almost all cases functioned well with at least one viral or in
2 3 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 each of the cell lines suggests that inefficient replication by
mixed combinations did not result from poor viral protein
-* expression. Rather, deficiencies probably reflected less ef-
fective interactions among the three essential components,
the ori, viral El and E2 proteins, and the host replication
Ip*_ _machinery.
Replication of the HPV-11 on Plasmid in Different Cell
Lines. To examine whether replication of the HPV-11 ori
I II III IV V VI VII plasmid could occur in other cell types in response to
replication proteins specified by the two viruses, we tested
murine fibroblasts (NIH 3T3), monkey COS-7 cells, and
human cervical carcinoma cells (C-33A, HeLa, SiHa). As in
El H B H B 293 and CHO cells, no replication could be detected when El
E2 H H and E2 expression vectors were absent (Fig. 3, group I). The2B B specific requirement for the HPV-ll ori was again evident
me point 1]2 '312 ]371 2 3 123because the HPV-ll protein expression vectors failed tomepoint3 1 2 3
replicate in any ofthe cell lines except for COS-7 (see below).
293 Plasmid p7072-99 replication was observed in most combi-
nations of El, E2, and host cells. The BPV-1 proteins
CHO replicated p7072-99 most efficiently in NIH 3T3 cells,
whereas HPV-ll proteins functioned best in COS-7 cells
plication of HPV-ll and BPV-l oni DNA by combi- (Fig. 3, groups II and V). This latter result can be attributed
V and BPV E1and E2 proteins in 293 and CHO cells, at least in part to the efficient translation (17) of El and E2
n of the HPV-11 plasmid p7072-99 by El and E2 mRNAs expressed from the SV40 ori-containing vectors that
fied by either HPV-11 (H) or BPV-1 (B). HPV-11 and replicated to high copy numbers in COS cells. Replication by
E2 proteins were expressed from pMT2-El, pMT2- either matched set of proteins was robust in C-33A cells, a
Lnd pCGE2, respectively. (b) Replication of the BPV-1 cervical carcinoma cell line that contains no known endog-
plasmid pUC/PstI by matched or mixed replication enous HPV DNA (20), but was weak in HeLa and SiHa cells
arized p7072-99 DNA was 32P-labeled and used as a that contain integrated HPV-18 and HPV-16 DNA, respec-
. Time points 1, 2, and 3 were collected at 36, 60, and that (Fig 3ntgrated Icnathand ofDPV
:troporation. Exposure was for 5 hr (a) or 16 hr (b) at tively (Fig. 3, group II). In contrast, the combination of HPV
rtensifying screens. El plus BPV E2 supported little or no replication in NIH 3T3,
HeLa, or SiHa cells (Fig. 3, group III). Similarly, only
lements-i.e., an ori must be present in p7072- marginal replication by BPV-1 El plus HPV-11 E2 was
ested the ability of the 72-kDa El and 48-kDa E2 detected in SiHa cells (Fig. 3, group IV). Replication in
IPV-1 expressed from the cytomegalovirus pro- mouse mammary C127, monkey kidney CV-1, and cervical
pCG vector (8) to function at the HPV-ll ori. carcinoma CaSki cells that contain integrated HPV-16 was
ion of the BPV-1 El and E2 proteins has previ- detected upon long exposure of the autoradiograms (data not
emonstrated and confirmed by Western blotting shown).
precipitation using specific antisera in some of Viral El and E2 Proteins Also Support Replication of
s used in this study (refs. 8 and 10; data not on-Containing Plasmids from Many Other Human and Animal
shown). In light of the specificity of ori recognition by large
tumor antigens of SV40 and polyomavirus, one might expect
that the papillomaviral El protein would confer similar
restricted ori recognition. Surprisingly, the heterologous
BPV-1 proteins were able to replicate p7072-99 in these two
cell lines with efficiencies comparable to those achieved by
the homologous HPV-11 proteins (Fig. 2a, group VII). More-
over, both sets of viral replication proteins were able to
function in 293 cells on the whole HPV-11 genomic DNA
excised from a cloning vector (C.-M.C., G. Dong, T.R.B.,
and L.T.C., unpublished results). In CHO cells, the combi-
nation of BPV-1 El protein plus HPV-11 E2 also replicated
p7072-99 effectively, whereas HPV-11 El plus BPV-1 E2
functioned very weakly, if at all. The mixed combinations of
the two sets of viral proteins weakly supported replication in
293 cells (Fig. 2a, groups V and VI).
We also examined the abilities of matched or mixed
combinations of the viral proteins to replicate the BPV-1 ori
plasmid pUC/PstI (10). In agreement with previous reports,
the homologous BPV-1 proteins were proficient in supporting
BPV-1 ori replication (Fig. 2b). With the exception of the
combination ofHPV El plus BPV E2, which failed to support
replication in CHO cells, all other combinations replicated
the BPV-1 ori weakly in CHO and 293 cells (Fig. 2b).
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FIG. 3. Replication of the HPV-11 ori-containing plasmid
p7072-99 in different cell lines. Pst I-linearized p7072-99 was used as
the hybridization probe except for the experiment in COS-7, for
which the HPV-11 URR fragment isolated from pUR23-3 was used.
Exposure was for 3 hr for COS-7 cells, 6 hr for C-33A cells, and 46
hr for NIH 3T3, HeLa, and SiHa cells.
a
El
E2
time point 1
293
CHO
b
tii
FIG. 2. Re
nations of HPI
(a) Replicatioi
proteins specif
BPV-1 El and
E2, pCGEag, a
ori-containing
proteins. Line
probe for both
84 hr after elec
-700C with in
specific cis e
99. We also to
proteins of B
moter of the
The expressi
ously been d4
and immuno'
the cell liner
Biochemistry: Chiang et al.
Proc. Natl. Acad. Sci. USA 89 (1992)
CHO 293 DISCUSSION
El H B
E2 H B
I
time point 1 2 3 1 2 3 1 2 3
HPV-18 4N-
HPV-1 6
1 r
1 2 3 1
9..
HPV-7 *a_
HPV-6b
. _ _ _
.aHPV-1 S
CRPV -*~
FIG. 4. Replication of different papillomaviru
plasmids by HPV-11 and BPV-1 El and E2 proteins
cells. Plasmids pUR71, pUR11, pUR51, pUR81, and
URRs from CRPV, HPV-1, HPV-6b, HPV-7, and I
tively (21). pUR32 contains the HPV-18 URR i
orientation to that in pUR31 (21). The 32P-labeled
pCAT-A (21), common to these pUR plasmids, v
hybridization probe. Exposure was for 6 hr.
Papimaviruses. The reciprocal substitution
E2 proteins specified by HPV-ll and BPV-1 i
functionally conserved viral proteins and m
initiation of papillomavirus DNA replication.
generality, in similar replication studies we u
URRs (21) from HPV-1 and HPV-7 (both oi
cutaneous skin), HPV-6b, HPV-16, and HPV-
for mucosal epithelia), and cottontail rabbit I
(CRPV, with trophism to cutaneous skin). Eac
able to replicate in 293 and CHO cells in the pre
set ofHPV-ll or BPV-1 replication proteins (F
the cloning vector without URR sequences di(
shown). DNA sequence alignment among the
other HPVs revealed a partially conserved regi
1 (Fig. 5), which corresponds to the ori of BP'
HPV-11 (C.-M.C., G. Dong, T.R.B., and L
lished results). We infer that this conserved re8
the replication origin of these viruses.
H B
We report the autonomous replication of HPV URR-
H containing plasmids in transiently transfected cells. As with
H B BPV-1 (8, 9), replication required viral El and E2 proteins.
-23 Since the vectors used for cloning the -URR or for expressing
L viral proteins did not replicate, we infer that the papilloma-
virus ori was contained in the conserved region in each of the
URRs (Fig. 5). All papillomaviral E2 proteins regulate viral
^*transcription through binding to the consensus ACCN6GGT
^*tw E2-responsive sequences. We now demonstrate that its role
inDNA replication is similarly conserved and that ori-binding
El proteins also appear to function analogously.
Quite unexpected was our observation that the ori of each
of the eight papillomaviruses tested was replicated by either
_ _ HPV-11 or BPV-1 replication proteins (Figs. 2 and 4). In
addition, the HPV-11 and BPV-1 ori sequences were recog-
nized by mixed combinations of the viral El and E2 proteins.
*4 Overall, the ori sequences of HPVs appeared to be promis-
cuous and were able to replicate well in response to either
HPV-11 or BPV-1 replication proteins in rodent and mam-
malian cell lines of epithelial or fibroblast lineage. The BPV-1
ori functioned better with the homologous than with the
s ori-containing heterologous viral proteins. Whether this preference ex-
in CHO and 293 tended to cell lines other than 293 and CHO cells was not
i pUR41 contain tested. Nevertheless, BPV-1 replication proteins function in
HPV-16, respec- human and rodent cells on the homologous ori (refs. 8 and 10;
n the opposite this study).
I cloning vector Densitometric tracing of autoradiograms indicated that
within one experiment in a given cell line, the efficiencies of
replication of different papillomaviral ori plasmids in re-
of the El and sponse to different combinations of viral proteins were within
is indicative of 35-fold of one another (data not shown). However, transient
echanisms for replication assays emphasize qualitative rather than quanti-
To test their tative results because factors affecting the overall efficiency
sed the cloned of replication are many, including the relative and absolute
f which infect amounts of the viral proteins expressed and the interactions
.18 'all t h- among ori sequences, viral proteins, and host proteins. In(allrophiC addition, transfection efficiency becomes a factor when dif-papillomavirus ferent cell lines used. Despite this uncertainty about
:h plasmidwas replication efficiencies, it is obvious that the interactions
sence ofeither between the cis elements and trans factors for papillomavi-
lig. 4), whereas ruses are more conserved than for the other members of the
d not (data not papovavirus family, SV40 and polyomavirus, that do not
se and several replicate in response to such mixed combinations. The rep-
ion spanning nt lication specificities of SV40 and polyomavirus rely on the
V-1 (9, 10) and species-specific interaction between large tumor antigen and
,.T.C., unpub- cellularDNA polymerase a/primase complex and the single-
1ion represents stranded DNA binding protein (replication factor A) (1, 2,
22-24). On the basis of our results, it is likely that a similar
.1 60.
HPV-7 ATGTTTAATAATTGT ACAGTTACTAAAG GGCGTA ACCCAAACGGT CCGA=G GAA
.7774 7815. .1 64.
HPV-1 ACGTICGTAAAAA TCTAAAGTGAT GATTGTTGTTGTTXACTACCATCAT TCA TTATTCTAGTTAC AACAAG ACIAG&rAl ATATGCCAGAAGTAA
.7861 7902. .1 61.
HPV-6b ACCGGTTTCG TTATCCACACCCTACATATTT CCTTC TTATACTTAATAACAATCTT GGTTTAAAAAATA GGAGGGACCrGA MT TCAACCGAAACGT
.7892 7933. .1 61.
HPV-11 ACCGGTTCGZGiTACCCACACCCTACATATTT CCTTC TTATACTTAATAACAATCTT AGTTTAAAAAAGA GGAGGG ACCG OAAk IT TCAACC CGAT
.7859 7901. .1 61.
HPV-16 ACCGTTTT TACACATTTACAAGCAACTTATATAA TAATACTAAACTACAATAAT TCATGTATAAAACTAAG GGCGTAACCGAAATCGGT TGAACCGA&ACG
.7822 7857. .1 69.
HPV-18 ACCGAAATAGTTGGGCAGCACATACTATACTTTTCAT TAATACTTT TAACAATTGT AGTATATAAAAAAG GGAGTAArcr&AAACI CGG&CCGAAAACGQ
.47 1.7868 7827.
CRPV ACCGTATCrAITITTCTGG CCATTACATGTTT CTTMATTATTGTTACCAACAAC CAT CATTAAA TCAAAGTG CATAACA^CCAT
.27 1. .7945 7895.
BPV- 1 AACGGTGATGGT GTGATTATTGTTAACAACAAT TATTCACTGGGAAAAAATACATAGTCTTTACTT ACCGGTTTCGGT
I I
FIG. 5. Alignment ofthe putative papillomavirus origin sequences. Conserved sequences around nt 1 are in bold type. An (A + T)-rich region
is present to the 5' side ofnt 1 in BPV-1 but to the 3' side on the sense strand in all the other papillomaviruses. The consensus E2 binding sequences
are underlined. The minimal BPV-1 ori (9, 10) is bracketed. The HPV-7 sequence upstream of nt 1 also exhibited extensive homology (H. Delius,
personal communication). Dots denote nucleotide coordinates for which the genomic positions are given. Gaps were introduced to achieve
maximal homology. DNA sequences were obtained from published data. Alignments of the ori sequences of many other papillomaviral types
are available upon request.
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restriction, but not as strict, also exists for papillomaviruses.
It would be interesting to determine whether various com-
binations ofEl and E2 proteins show differential affinities for
such cellular replication protein components.
Another surprising observation was that HPV replication
was observed in cells of epithelial and fibroblast lineage from
a wide range ofmammalian cells (Figs. 2-4), in contrast to the
strict species and tissue tropisms these viruses exhibit in vivo.
Our results demonstrate that the in vivo specificities are not
entirely due to direct restrictions on viral replication. Host
transcription factors required to activate expression of the
viral replication genes would appear to play a dominant role.
It is worth noting that the one cervical carcinoma cell line
that contains no HPV DNA, C-33A, supported robust
HPV-1l DNA replication, whereas all three HPV-containing
cervical carcinoma cell lines tested, HeLa, SiHa, and CaSki,
supported HPV-ll ori replication poorly, if at all. We spec-
ulate that a deficiency in supporting viral DNA replication
might have led to viral integration in these carcinoma cells in
the first place. The development of a HPV DNA replication
assay system should make it possible to search for pharma-
ceutical inhibitors of this major group of human pathogens.
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